Takeda Pharmaceutical Co Ltd (TAK)
14.99
+0.16
(+1.08%)
USD |
NYSE |
Mar 05, 11:46
Takeda Pharmaceutical Market Cap: 47.52B for March 5, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Keros Therapeutics Inc | 455.51M |
Nxera Pharma Co Ltd | 586.15M |
PeptiDream Inc | 2.314B |
Healios KK | 175.02M |
AnGes Inc | 86.58M |
Market Cap Related Metrics
PE Ratio | 35.21 |
PS Ratio | 1.584 |
PEG Ratio | 5.819 |
Price to Book Value | 1.006 |
Price to Free Cash Flow | 9.430 |
Price | 14.99 |
Earnings Yield | 2.84% |
PEGY Ratio | 3.445 |
Operating PE Ratio | 14.04 |
Normalized PE Ratio | 35.21 |